These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1259932)

  • 21. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
    Sueishi K; Nanno S; Tanaka K
    Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemotaxis of selected cell types to connective tissue degradation products.
    Stecher VJ
    Ann N Y Acad Sci; 1975 Jun; 256():177-89. PubMed ID: 169719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of fibrinopeptide B in early atherosclerotic lesion formation.
    Singh TM; Kadowaki MH; Glagov S; Zarins CK
    Am J Surg; 1990 Aug; 160(2):156-9. PubMed ID: 2382767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonrandom catabolism of proteins in the formation of antigenic peptide fragments.
    Thomas DW; Schauster JL; Hoffman MD; Wilner GD
    J Immunol; 1985 Aug; 135(2):1259-63. PubMed ID: 3874235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
    Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel venombin B from agkistrodon contortrix contortrix: evidence for recognition properties in the surface around the primary specificity pocket different from thrombin.
    Amiconi G; Amoresano A; Boumis G; Brancaccio A; De Cristofaro R; De Pascalis A; Di Girolamo S; Maras B; Scaloni A
    Biochemistry; 2000 Aug; 39(33):10294-308. PubMed ID: 10956019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The action of Russell's viper venom on fibrin formation and fibrinolysis in vivo.
    Woodhams BJ; Than T; Than T; Hutton RA
    Br J Haematol; 1989 Jan; 71(1):107-11. PubMed ID: 2492816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of matrix composition on chemotaxis response of monocytes stimulated by monocyte chemoattractant protein-1].
    Kukhtina NB; Aref'eva TI; Aref'eva AM; Krasnikova TL
    Ross Fiziol Zh Im I M Sechenova; 2003 Dec; 89(12):1577-81. PubMed ID: 14870496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis.
    Ebert RF; Bell WR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7318-22. PubMed ID: 6580646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of desarginine fibrinopeptide B in human blood.
    Eckhardt T; Nossel HL; Hurlet-Jensen A; La Gamma KS; Owen J; Auerbach M
    J Clin Invest; 1981 Mar; 67(3):809-16. PubMed ID: 7204556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of human fibrinopeptides by high-performance liquid chromatography.
    Kehl M; Lottspeich F; Henschen A
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Functional and diagnostic significance of A-, Bbeta 1-42 and Bbeta 15-42 peptide fragments of fibrin(ogen)].
    Makogonenko EM; Lugovskoĭ EV; Kolesnik LA; Kudinov SA
    Ukr Biokhim Zh (1978); 1992; 64(4):78-82. PubMed ID: 1448878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinopeptide B and aggregation of fibrinogen.
    Shainoff JR; Dardik BN
    Science; 1979 Apr; 204(4389):200-2. PubMed ID: 155308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acid sequences of lamprey fibrinopeptides A and B and characterizations of the junctions split by lamprey and mammalian thrombins.
    Cottrell BA; Doolittle RF
    Biochim Biophys Acta; 1976 Dec; 453(2):426-38. PubMed ID: 999898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of cryoprofibrin in fibrinogen-fibrin conversion.
    SHAINOFF JR; PAGE IH
    J Exp Med; 1962 Nov; 116(5):687-707. PubMed ID: 13988371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
    Sterrenberg L; van Liempt GJ; Nieuwenhuizen W; Hermans J
    Thromb Haemost; 1984 Jul; 51(3):398-402. PubMed ID: 6238443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of fibrin degradation products in neutrophil recruitment to the lung.
    Leavell KJ; Peterson MW; Gross TJ
    Am J Respir Cell Mol Biol; 1996 Jan; 14(1):53-60. PubMed ID: 8534486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.